Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00579124 · ClinicalTrials.gov registry record · Phase 2

CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation for T and B Cell Depletion

A Phase 2 study, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
Phase 2
Development phase
93
Enrollment target

NCT00579124 is a Phase 2 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 93 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00579124, a Phase 2 study, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
Phase 2
Development phase
93 participants
Enrollment target

Study Summary

This is a pilot study with 2 strata to evaluate engraftment and graft vs. host disease (GVHD) in patients receiving unrelated or partially matched related donor peripheral stem cells using the CliniMACS system to positively deplete T cells to prevent severe GVHD. Feasibility will be tested, focusing on engraftment, treatment-related mortality (with a specific focus on interstitial pneumonitis) and severe GVHD.

Interventions

  • DEVICE CliniMACs

Trial Details

FieldValue
Enrollment Target 93 participants
Start Date 2005-01
Est. Completion 2017-12-30
Phase Phase 2

Sponsor

Children's Hospital of Philadelphia

431 total trials

What the Registry Record Tells You About NCT00579124

The ClinicalTrials.gov registry entry for NCT00579124 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which CliniMACs is the first listed.

NCT00579124 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00579124 about?

NCT00579124 is a clinical study titled "CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation for T and B Cell Depletion". This is a pilot study with 2 strata to evaluate engraftment and graft vs. host disease (GVHD) in patients receiving unrelated or partially matched related donor peripheral stem cells using the CliniMACS system to positively deplete T cells to prevent severe GVHD. Feasibility will be tested, focusing...

What is the current status of trial NCT00579124?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 93 participants. The study started on 2005-01. Estimated completion is 2017-12-30.

What interventions are being tested in trial NCT00579124?

The interventions under investigation include: CliniMACs (DEVICE).

Who is sponsoring clinical trial NCT00579124?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.